Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Erlangen-Nürnberg Medical School
About this trial
Aim of the study is to improve the diagnosis of food allergy and hypersensitivity. Intestinal homogenates will be used to determine total IgE, specific IgE, tryptase, histamine and inflammation parameters (IFNgamma, TNFalpha). These data will be correlated with serum values and disease status. In addition, organoids from duodenal tissue will be isolated and cultured in vitro and stimulated with the major food allergens. The gene and protein expression will be checked to identify relevant biomarkers.
Eligibility criteria
Qualifiers
informed consent
patients with suspected food allergy or hypersensitivity
healthy controls with indications for endoscopic diagnostics, e.g. tumour history within the family, exclusion of gastritis
Disqualifiers
pregnant person
Trial design
Treatments tested in this trial
- biopsy sampling
Treatment groups
115 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov